Common use of Charging Study Subjects Clause in Contracts

Charging Study Subjects. Neither Principal Investigator nor Institution will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.1

Charging Study Subjects. Neither Principal Investigator nor Institution will not charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.1Agreement or the agreement between CRO and Principal Investigator.

Charging Study Subjects. Neither Principal Investigator nor Institution will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.1.

Charging Study Subjects. Neither Principal Investigator nor Institution will not charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this AgreementAgreement or the agreement between CRO and Principal Investigator. 5.1 Účtování poplatků subjektům klinického hodnocení. 5.1Zdravotnické zařízení nebude za hodnocený lék (viz xxxxxx 0, Xxxxxxxxx xxx) ani za jiné služby, které hradí CRO podle této smlouvy nebo podle smlouvy mezi CRO a hlavním zkoušejícím, nic účtovat subjektům klinického hodnocení ani plátcům třetí strany.

Charging Study Subjects. Neither Principal Investigator nor Institution will not charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this AgreementAgreement or the agreement between CRO and Principal Investigator. 5.1skúšania alebo platiteľovi - tretej strane účtovať za skúšaný liek (pozri xxxx 0, Xxxxxxx liek), ani za žiadne služby, ktoré v rámci tejto zmluvy alebo zmluvy medzi CRO a hlavným skúšajúcim prepláca CRO.

Charging Study Subjects. Neither Institution and Principal Investigator nor Institution will not charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.15.2

Charging Study Subjects. Neither Principal Investigator nor Institution will not charge a Study Subject or third-third- party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this AgreementAgreement or the agreement between CRO and Principal Investigator. 5.1 Poplatky od účastníkov klinického skúšania. 5.1Inštitúcia nebude účastníkovi klinického skúšania alebo platiteľovi - tretej strane účtovať za skúšaný liek (pozri časť 8, Skúšaný liek), ani za žiadne služby, ktoré v rámci tejto zmluvy alebo zmluvy medzi CRO a hlavným skúšajúcim prepláca CRO.

Charging Study Subjects. Neither Principal Investigator nor Institution The Health Services Provider will not charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.1Agreement or the agreement between CRO and Principal Investigator.

Charging Study Subjects. Neither Principal Investigator nor Institution Institute will charge a Study Subject or third-party payer for Investigational Drug (see Section 8, Investigational Drug) or for any services reimbursed by CRO under this Agreement. 5.15.2